Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Colorectal Disease
Published in: International Journal of Colorectal Disease 6/2015

01-06-2015 | Original Article

Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision

Authors: Radhika K. Smith, Robert D. Fry, Najjia N. Mahmoud, E. Carter Paulson

Published in: International Journal of Colorectal Disease | Issue 6/2015

Login to get access

Abstract

Purpose

While the standard of care for patients with rectal cancer who sustain a complete clinical response (cCR) to chemoradiotherapy (CRT) remains proctectomy with total mesorectal excision, data suggests that non-operative management may be a safe alternative. The purpose of this study is to compare outcomes between patients treated with CRT that attained a cCR and opted for a vigilant surveillance to those of the patients who had a complete pathologic response (cPR) following proctectomy.

Method

This is a retrospective review of patients treated for adenocarcinoma of the rectum who achieved either a cCR or a cPR following CRT. Patients with a cCR were enrolled in an active surveillance program which included regularly scheduled exams, proctoscopy, serum carcinoembryonic antigen (CEA), endorectal ultrasound, and cross-sectional imaging. Outcomes were compared to those patients who underwent proctectomy with a cPR. Our primary outcome measures were post-treatment complications, recurrence, and survival.

Results

We reviewed 18 patients who opted for surveillance after cCR and 30 patients who underwent proctectomy after a cPR. No non-operative patients had a documented treatment complication, while 17 patients with cPR suffered significant morbidity. There were two recurrences in the active surveillance group, one local and once distant, both treated by salvage resection with no associated mortality at 54 and 62 months. In the cPR group, one patient had a distant recurrence 24 months after surgery which was managed non-operatively. This patient died of unrelated causes 35 months after surgery.

Conclusions

Active surveillance can be a safe option that avoids the morbidity associated with proctectomy and preserves oncologic outcomes.
Literature
1.
Kapiteijn E et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–46CrossRefPubMed
2.
MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341(8843):457–60CrossRefPubMed
3.
Sauer R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–40CrossRefPubMed
4.
Heald RJ, MacFarlane JK, Ryall RD (1993) Surgical lateral clearance in resected rectal carcinomas: a multivariate analysis of clinicopathologic features. Cancer 72(5):1806CrossRefPubMed
5.
Smith RBR, Hedick TL, Majmoud NN, Paulson EC, (2014) The impact of body mass index on postoperative outcomes in patients undergoing proctectomy for rectal cancer: a NSQIP analysis. Dis Colon Rectum
6.
Russell MM et al (2014) Comparative Effectiveness of Sphincter-Sparing Surgery Versus Abdominoperineal Resection in Rectal Cancer: Patient-Reported Outcomes in National Surgical Adjuvant Breast and Bowel Project Randomized Trial R-04. Ann Surg
7.
Guillem JG et al (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241(5):829–36, discussion 836-8CrossRefPubMedCentralPubMed
8.
Maas M et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11(9):835–44CrossRefPubMed
9.
Habr-Gama A et al (2006) Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10(10):1319–28, discussion 1328-9CrossRefPubMed
10.
Habr-Gama A et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4):711–7, discussion 717-8PubMedCentralPubMed
11.
Smith JD et al (2012) Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 256(6):965–72CrossRefPubMed
12.
Maas M et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29(35):4633–40CrossRefPubMed
13.
Longo WE et al (1998) Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program. Ann Surg 228(1):64–70CrossRefPubMedCentralPubMed
14.
Luna-Perez P et al (2001) Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma. Rev Invest Clin 53(5):388–95PubMed
15.
Petrelli NJ et al (1993) Morbidity and mortality following abdominoperineal resection for rectal adenocarcinoma. Am Surg 59(7):400–4PubMed
16.
Maas CP et al (1998) Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome. Br J Surg 85(1):92–7CrossRefPubMed
17.
Nesbakken A et al (2000) Bladder and sexual dysfunction after mesorectal excision for rectal cancer. Br J Surg 87(2):206–10CrossRefPubMed
18.
Dalton RS et al (2012) A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis 14(5):567–71CrossRefPubMed
19.
Hiotis SP et al (2002) Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 194(2):131–5, discussion 135-6CrossRefPubMed
Metadata
Title
Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision
Authors
Radhika K. Smith
Robert D. Fry
Najjia N. Mahmoud
E. Carter Paulson
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 6/2015
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-015-2165-2

Other articles of this Issue 6/2015

International Journal of Colorectal Disease 6/2015 Go to the issue

Original Article

Long-term effects of a regional care pathway for patients with rectal cancer

Original Article

A clinical model for predicting lymph node metastasis in submucosal invasive (T1) colorectal cancer

Letter to the Editor

Necrotizing fasciitis—a sinister complication of hemorrhoidectomy

Original Article

Colorectal neoplasia in IBD—a single-center analysis of patients undergoing proctocolectomy

Original Article

Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy

Original Article

Contrast medium at the site of the anastomosis is crucial in detecting anastomotic leakage with CT imaging after colorectal surgery